Provided by Tiger Trade Technology Pte. Ltd.

Xencor

27.80
+0.80002.96%
Pre-market: 27.74-0.0600-0.22%07:18 EDT
Volume:753.11K
Turnover:20.90M
Market Cap:2.06B
PE:-12.77
High:28.16
Open:27.30
Low:27.07
Close:27.00
52wk High:28.16
52wk Low:7.71
Shares:74.13M
Float Shares:54.25M
Volume Ratio:0.54
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1768
EPS(LYR):-1.2400
ROE:-29.07%
ROA:-16.83%
PB:4.10
PE(LYR):-22.42

Loading ...

Xencor Advances Dual-Antibody Cancer Trial, Keeping Investor Focus on XNCR

TIPRANKS
·
Aug 14

Analysts’ Top Healthcare Picks: Xencor (XNCR), Revolution Medicines (RVMD)

TIPRANKS
·
Aug 10

Canada's DRI Healthcare Q2 Income Rises, Helped by Milestone Events in Royalty Portfolio

Reuters
·
Aug 08

Xenetic Biosciences Q2 Royalty Revenue Rises on Takeda Sublicense

Reuters
·
Aug 07

Verastem Q2 Revenue Jumps on New Product Sales and Milestone

Reuters
·
Aug 07

Xencor Price Target Raised to $30.00/Share from $26.00 by Wedbush

Dow Jones
·
Aug 06

Cancer Drugmaker Genmab's H1 Revenue Rises, Lifts FY Outlook

Reuters
·
Aug 06

Analysts’ Opinions Are Mixed on These Healthcare Stocks: GoodRx Holdings (GDRX), Xencor (XNCR) and PepGen Inc. (PEPG)

TIPRANKS
·
Aug 06

Xencor price target raised to $44 from $43 at Cantor Fitzgerald

TIPRANKS
·
Aug 06

RBC Capital Adjusts PT on Xencor to $20 From $19, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 06

Agenus Q2 Revenue Rises on Access and Royalty Income

Reuters
·
Aug 06

Regenxbio Q2 Revenue Surges on AbbVie Milestone Payment

Reuters
·
Aug 06

Aclaris Therapeutics Q2 Revenue Beats Analyst Estimates

Reuters
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Xencor (XNCR), Alpha Teknova (TKNO) and Solventum Corporation (SOLV)

TIPRANKS
·
Aug 06

Barclays Reaffirms Their Buy Rating on Xencor (XNCR)

TIPRANKS
·
Aug 06

Xencor, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Xencor Q2 EPS $(0.29) Beats $(0.79) Estimate, Sales $51.200M Beat $18.922M Estimate

Benzinga Earnings
·
Aug 06

Xencor reports Q2 EPS (29c), consensus (84c)

TIPRANKS
·
Aug 06

Biopharma Firm Xencor's Q2 Revenue Beats on Royalty Revenue, Milestone Payments

Reuters
·
Aug 06

Xencor Q2 FY26 Loss Before Income Taxes Narrows to $21.92 Million; Revenue Rises 17.46% to $51.22 Million

Reuters
·
Aug 06